Parham Academy LLC
Global learning systems in Science and Medicine


Our news & hot issues


ISI Impact factor= 5.49 (Q1)



(Reverse chronological order)

Molecular modelling, molecular dynamics simulations and in vitro evaluation of Berberine as an inhibitor of MAP kinase and PI3K pathway. (2017: Accepted as Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Molecular modelling of berberine derivatives as inhibitors of smoothened receptor using a new drug discovery script for a large numbers of compounds. (2017: Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Is it the right way to use intercalating agents as inhibitors of MAP kinase pathway? A challenging issue using berberine with dual cellular functionality applied in breast cancer cell models. (2017: Poster presentation; Role: presenter), In: "Tumour Microenvironment – Basic Science to Novel Therapies", 15th June 2017, Nottingham, UK.

Molecular modelling and molecular dynamics simulations of a new berberine derivative as a dual RAF inhibitor for treatment of drug resistance acquired in melanoma. (2016: Oral presentation; Role: Presenter), In: "Pharmacology", British Pharmacological Society, 13th December, London, UK. (Abstract)

Tissue regeneration in mammals: Role of Oct4 gene expression in treatment of infectious diseases. (2010: Poster presentation; Role: Presenter) "10th International MEEGID Conference (Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases)", Nov. 2010, Amsterdam, Netherlands (Elsevier).

A new cell line detected in mouse: A novel theory of stem cell applications in tissue regeneration. (2010: Oral presentation; Role: Presenter) "11th Iranian Genetics Congress", Shahid Beheshti University, May. 2010, Tehran.
ASPET annual meeting




Author watson Home 15:42:17 | | | printer friendly | | create pdf of this news item


Our article: Therapeutic miRNAs


 Pharmacological Research




Headlines





Date published: not known
Details

»When you don't want things to stick
»The circuits of itching and scratching
»Sequencing each cell of the nematode
»Unusual star may be supernova debris
»Identification of a new injection system
»A new therapeutic target in view?
»Modeling a pregnancy disorder
»Treating a tumor to metastasize
»Sharing data, protecting privacy
»Collaborative governance


Date published: not known
Details

»A Chinese Perspective on Receptors and Receptor Regulation [Commentary-Molecular Pharmacology in China]
A receptor is a protein molecule that receives chemical signals from outside a cell, which enables ...
»Progress in Pharmacological Sciences in China [Minireview-Molecular Pharmacology in China]
Pharmacology is the science that investigates the interactions between organisms and drugs and thei ...
»The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases [Minireview-Molecular Pharmacology in China]
Temperature-sensitive transient receptor potential (TRP) channels such as TRPA1 and TRPV1 have been ...
»Phosphorylation of G Protein-Coupled Receptors: From the Barcode Hypothesis to the Flute Model [Minireview-Molecular Pharmacology in China]
Seven transmembrane G protein-coupled receptors (GPCRs) are often phosphorylated at the C terminus ...
»MG53: Biological Function and Potential as a Therapeutic Target [Minireview-Molecular Pharmacology in China]
MG53 (also known as tripartite motif, TRIM72) is a cardiac and skeletal muscle-specific TRIM-family ...
»Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations for Improved Tumor Therapy [Minireview-Molecular Pharmacology in China]
The tumor microenvironment participates in all stages of tumor progression and has emerged as a pro ...
»Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives [Minireview-Molecular Pharmacology in China]
Screening for circulating tumor cells (CTCs) has been identified as one approach to ultrasensitive ...
»The Emerging Role of Cables1 in Cancer and Other Diseases [Minireview-Molecular Pharmacology in China]
Cdk5 and Abl enzyme substrate 1 (Cables1) is an adaptor protein that links cyclin-dependent kinase ...
»Advances in Hypoxia-Mediated Mechanisms in Hepatocellular Carcinoma [Minireview-Molecular Pharmacology in China]
Hepatocellular carcinoma (HCC) is the fifth most common and the third most deadly malignant tumor w ...
»Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNF{alpha} in Vascular Endothelial Cells through a PXR-Dependent Mechanism [Molecular Pharmacology in China]
Excessive activation of the NLRP3 inflammasome is implicated in cardiovascular diseases. Statins ex ...


Date published: not known
Details

»Limb-Enhancer Genie: An accessible resource of accurate enhancer predictions in the developing limb
»Polymodal allosteric regulation of Type 1 Serine/Threonine Kinase Receptors via a conserved electrostatic lock
»Host population structure impedes reversion to drug sensitivity after discontinuation of treatment
»Spatial dynamics of synthetic microbial mutualists and their parasites
»Neuron’s eye view: Inferring features of complex stimuli from neural responses
»Multidomain analyses of a longitudinal human microbiome intestinal cleanout perturbation experiment
»Efficient and accurate causal inference with hidden confounders from genome-transcriptome variation data
»Extracting replicable associations across multiple studies: Empirical Bayes algorithms for controlling the false discovery rate
»Ten simple rules to initiate and run a postdoctoral association
»Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
»An optimal strategy for epilepsy surgery: Disruption of the rich-club?
»The application of project-based learning in bioinformatics training


Date published: not known
Details


THE FOUNDER and CEO

Parham Jabbarzadeh Kaboli, PhD

Research scientist
in molecular medicine


Expert in:

Cell and molecular Biology
Modelling and drug discovery
Cancer signaling pathways

H-index= 3 (Google Scholar)
i10-index= 3
Overall ISI impact factor= 18.15
Overall citation= 110 (Google Scholar)

Memberships:

The American Society for Pharmacology and Experimental Therapeutics (ASPET)

American Association for Cancer Research (AACR)

European Association for Cancer Research (EACR)

American Association for Advancement of Science (AAAS)



CONTACT INFORMATION


Affiliation:
Department of Biomedical Science,
Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
UPM Serdang 43400,
Selangor, Malaysia

E-Mail: parham@gromacs.net
Telegram: telegram.me/parhamacademy
Featured Publication





View the full list.
Archives

Welcome

Username:

Password:



[ ]







This site is powered by Parham Academy.
This site is powered by Parham Academy.
Render time: 0.1717 sec, 0.0320 of that for queries.